Cargando…

Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review

Detalles Bibliográficos
Autores principales:	Gaudette, Étienne, Rizzardo, Shirin, Wladyka, Sasha B., Rahman, Tuhin, Pothier, Kevin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260241/ https://www.ncbi.nlm.nih.gov/pubmed/37308215 http://dx.doi.org/10.1503/cmaj.230339

Ejemplares similares

Le Canada manque-t-il le bateau? Un inventaire des médicaments approuvés à l’international entre 2016 et 2020 qui n’ont pas été soumis à Santé Canada
por: Gaudette, Étienne, et al.
Publicado: (2023)

Pharmaceutical security for Canada
por: Lee, Shoo K., et al.
Publicado: (2022)

COVID-19’s Limited Impact on Drug Shortages in Canada
por: Gaudette, Étienne
Publicado: (2020)

HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers?
por: Gaudette, É, et al.
Publicado: (2022)

Integrating research into clinical practice: challenges and solutions for Canada
por: Lamontagne, François, et al.
Publicado: (2021)

Medical Topography of Upper Canada
Publicado: (1820)

Excess mortality, COVID-19 and health care systems in Canada
por: McGrail, Kimberlyn
Publicado: (2022)

Ensuring equitable access to cancer care for Black patients in Canada
por: Ezeife, Doreen A., et al.
Publicado: (2022)

Assessing the need for Black mentorship within residency training in Canada
por: Egbedeyi, Onaope, et al.
Publicado: (2022)

Rare diseases: Canada’s “research orphans”
por: Gupta, Samir
Publicado: (2012)

The war in Ukraine and refugee health care: considerations for health care providers in Canada
por: Greenaway, Christina, et al.
Publicado: (2022)

Prostate cancer screening in Black men in Canada: a case for risk-stratified care
por: Otiono, Kikachukwu, et al.
Publicado: (2022)

Informing COVID-19 vaccination priorities based on the prevalence of risk factors among adults in Canada
por: McAlister, Finlay A., et al.
Publicado: (2021)

Canada’s response to the initial 2 years of the COVID-19 pandemic: a comparison with peer countries
por: Razak, Fahad, et al.
Publicado: (2022)

Physician workforce planning in Canada: the importance of accounting for population aging and changing physician hours of work
por: Islam, Rabiul, et al.
Publicado: (2023)

Neoliberalism, conflict of interest, and the governance of health research in Canada
por: Lewis, Steven
Publicado: (2010)

Marketing before patenting: implications for price controls in Canada
por: Lexchin, Joel
Publicado: (2010)

Questioning physicians about health conditions at medical licensure registration: How should policy evolve in Canada?
por: Stergiopoulos, Erene, et al.
Publicado: (2023)

A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens
por: Berry, Isha, et al.
Publicado: (2022)

Radiation Oncology Device Approval in the United States and Canada
por: Beers, Craig A, et al.
Publicado: (2019)

The need to streamline approval processes for clinical research in Canada
por: Lumia, Celeste M., et al.
Publicado: (2023)

Ups and downs of hypertension control in Canada: critical factors and lessons learned
por: Campbell, Norm RC, et al.
Publicado: (2022)

Public–private partnership alternative for a national pharmacare program in Canada
por: Nauenberg, Eric, et al.
Publicado: (2023)

Health Canada approves first drug for treatment of COVID-19
Publicado: (2020)

Epidemiology of ticks submitted from human hosts in Alberta, Canada (2000–2019)
por: Kanji, Jamil N., et al.
Publicado: (2022)

Keeping the GINA in the bottle: assessing the current need for genetic non-discrimination legislation in Canada
por: Pullman, Daryl, et al.
Publicado: (2010)

Improving community health and safety in Canada through evidence-based policies on illegal drugs
por: Wood, Evan, et al.
Publicado: (2012)

Prediction of therapeutic value of new drugs approved by health Canada from 2011−2020: A cross-sectional study
por: Lexchin, Joel
Publicado: (2023)

Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada
por: Morgan, Steven G
Publicado: (2007)

Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab
por: Chertkow, Howard, et al.
Publicado: (2021)

Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
por: Herder, Matthew, et al.
Publicado: (2016)

Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data
por: McClean, Alison R., et al.
Publicado: (2022)

National Dementia Strategies: What Should Canada Learn?
por: Chow, Selina, et al.
Publicado: (2018)

The changing face of missed appointments
por: Parsons, Jo, et al.
Publicado: (2023)

An Examination of Child Pedestrian Rule Compliance at Crosswalks around Parks in Montreal, Canada
por: Cloutier, Marie-Soleil, et al.
Publicado: (2022)

Critical Care Canada Forum 2020 Abstracts
Publicado: (2021)

Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020
por: Marras, Theodore K., et al.
Publicado: (2023)

The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges
por: DeBeck, Kora, et al.
Publicado: (2010)

Patient Preferences for Attributes of Health Canada Approved Weight Loss Medications Among Adults Living with Obesity in Canada: A Qualitative Study
por: Donnan, Jennifer, et al.
Publicado: (2022)

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqis58k3hf0c1rdui64m7hhiet